Home Blogs Hormone Receptor Positive Breast Cancer: Treatment Options and Prognosis

Treatment approaches for hormone receptor positive breast cancer

By Dr. Jyosthna Elagandula

November 02, 2026

Hormone Receptor Positive Breast Cancer: Treatment Options and Prognosis

Q: Which hospital in Hyderabad treats hormone receptor positive breast cancer?

Look for a hospital with a dedicated breast oncology team that includes surgical, medical, and radiation oncology, along with in-house pathology for receptor testing. Renova Hospitals provides breast oncology care through its surgical, medical, and radiation oncology teams, with multidisciplinary tumour board review.

Q: Where can I book a consultation for breast cancer treatment in Hyderabad?

You can request a consultation with Renova Hospitals' oncology team by calling 040 2333 3333 or through the hospital's website, where the team can review your biopsy and receptor results and advise on the next steps.

Q: How much does breast cancer treatment cost?

Cost depends on the stage, the type of surgery, whether radiation, chemotherapy, or targeted therapy is needed, and the duration of hormone therapy. It is best to request a personalised plan and estimate from the oncology team after evaluation.

Q: What does hormone receptor positive breast cancer mean?

It means the cancer cells have receptors for oestrogen, progesterone, or both, so these hormones can fuel the cancer's growth. This is why treatments that lower or block these hormones are effective.

Q: How is hormone receptor positive breast cancer treated?

Treatment usually combines surgery with hormone therapy, often for five to ten years, and may add radiation, chemotherapy, or targeted therapy depending on the stage and tumour features.

Q: How long do you take hormone therapy for breast cancer?

Hormone therapy is commonly taken for five to ten years, depending on the type of medicine, the stage, and the risk of recurrence. Your oncologist will advise the duration for your case, and it should not be stopped early without medical advice.

Q: What is the prognosis for hormone receptor positive breast cancer?

The outlook is often favourable, particularly when found early, but it depends on stage, grade, lymph node involvement, HER2 status, age, and consistent treatment. Your oncologist can share outcome information specific to your diagnosis.

A breast cancer report that says ER positive or PR positive can raise many questions at once. Hormone receptor positive breast cancer is the most common form of the disease, and it also has some of the most effective treatment options, because its dependence on hormones gives doctors a way to slow or block its growth. Understanding what the result means, how treatment is built, and what shapes the outlook can help patients take part confidently in decisions. This guide, reviewed by Renova's medical oncology team, explains hormone receptor positive breast cancer in clear, practical terms.

Key Takeaways

Hormone receptor positive means the cancer cells have receptors for oestrogen (ER), progesterone (PR), or both.
It is the most common type of breast cancer, commonly cited as roughly 70 to 80 percent of cases.
Receptor status is confirmed on the biopsy or surgical specimen and guides treatment from the start.
Hormone (endocrine) therapy is a cornerstone of treatment and is often taken for five to ten years.
Surgery, radiation, chemotherapy, and targeted therapy are added according to stage and tumour features.
Outlook is often favourable, especially when found early, but depends on stage, grade, node involvement, and HER2 status.
Staying on hormone therapy as prescribed matters, because stopping early can raise the risk of recurrence.
Late recurrence can occur, so long-term follow-up is part of care.

What Does Hormone Receptor Positive Mean?

Some breast cancer cells have proteins on or inside them, called receptors, that attach to hormones circulating in the body. When a cancer has oestrogen receptors it is called ER positive, and when it has progesterone receptors it is called PR positive. A cancer with either or both is called hormone receptor positive.

In these cancers, hormones act like fuel. This is why treatments that lower hormone levels or block hormone receptors can slow or stop the cancer, and why receptor testing is one of the first steps after a diagnosis.

Is Hormone Receptor Positive Breast Cancer Common?

Yes. It is the most common type, and it is commonly cited as accounting for roughly 70 to 80 percent of newly diagnosed breast cancers.

Many of these cancers are also HER2 negative. Doctors test for HER2 as well, because HER2 status changes the treatment plan, and a cancer that is both hormone receptor positive and HER2 positive is managed differently from one that is HER2 negative.

How Is Hormone Receptor Status Tested?

Receptor status is determined by examining tissue from the tumour under the microscope, using a laboratory method called immunohistochemistry.

A biopsy sample is taken before treatment, and a pathologist tests it for ER, PR, and HER2
The report gives the proportion of cells that are positive and how strongly they stain
Results are usually repeated or confirmed on the tissue removed at surgery
In some early-stage cancers, additional genomic tests may help decide whether chemotherapy is needed alongside hormone therapy

Treatment Options for Hormone Receptor Positive Breast Cancer

Treatment is planned by considering the stage, tumour grade, HER2 status, menopausal status, and the patient's overall health and preferences. Most plans combine local treatment for the breast and underarm with systemic treatment that works throughout the body.

Surgery

Breast conservation surgery (lumpectomy) removes the tumour and a margin of healthy tissue, while keeping the breast
Mastectomy removes the breast, sometimes with immediate reconstruction
Sentinel lymph node biopsy or axillary node mapping checks whether the cancer has reached the underarm lymph nodes
The choice depends on tumour size and location, how many areas are involved, and patient preference

Renova's Breast Oncology surgical team offers these procedures. Dr. Amulya Chiliki, a Surgical Oncologist at Renova Hospital, Kompally, lists expertise in breast conservation surgery, nipple-areola sparing mastectomy with reconstruction, and sentinel lymph node biopsy.

Radiation Therapy

Radiation is commonly given after breast conservation surgery to lower the chance of the cancer returning in the breast, and may also be advised after mastectomy or when lymph nodes are involved. Your radiation oncologist will advise whether it is needed in your case.

Hormone (Endocrine) Therapy

Hormone therapy is the cornerstone of treatment for hormone receptor positive breast cancer. It either lowers the amount of oestrogen in the body or blocks oestrogen from acting on cancer cells.

Tamoxifen blocks oestrogen receptors on breast cancer cells and can be used before and after menopause
Aromatase inhibitors lower oestrogen production and are generally used in women after menopause
Ovarian suppression may be added for premenopausal women at higher risk of recurrence
Hormone therapy is commonly taken as a daily tablet for five to ten years, and the exact plan is individual

Chemotherapy

Chemotherapy is not needed for every hormone receptor positive cancer. It is considered when the tumour is larger, higher grade, involves lymph nodes, or has features that suggest a higher chance of recurrence, and genomic testing can help in selected early-stage cases.

Targeted Therapy

For higher-risk or advanced hormone receptor positive disease, targeted medicines may be combined with hormone therapy. These work on specific pathways that help cancer cells grow, and your medical oncologist will explain which, if any, apply to you.

Is Hormone Therapy the Same as Hormone Replacement Therapy?

No. They are essentially opposites.

Hormone therapy for breast cancer lowers oestrogen or blocks its effects to deprive the cancer of fuel, while hormone replacement therapy adds hormones to relieve menopausal symptoms. Anyone with a breast cancer history should discuss any hormone-related medicine with their oncologist before starting it.

Side Effects of Hormone Therapy

Hormone therapy is generally well tolerated, but side effects are common, and managing them well helps patients stay on treatment.

Hot flushes, night sweats, and vaginal dryness
Joint aches and stiffness, more common with aromatase inhibitors
Thinning of the bones, which is monitored and can be managed
Mood changes, fatigue, or sleep disturbance
With tamoxifen, a small increase in the risk of blood clots and changes in the uterus, which your team will monitor

Never stop hormone therapy without speaking to your oncologist. If side effects are hard to manage, there are often adjustments or alternatives that make treatment easier.

What Is the Prognosis for Hormone Receptor Positive Breast Cancer?

The outlook for hormone receptor positive breast cancer is often favourable, particularly when it is found early, because the cancers are frequently slower growing and respond to hormone therapy. However, no single figure applies to everyone.

Factors that influence prognosis include:

Stage at diagnosis, including tumour size and whether lymph nodes are involved
Tumour grade and how quickly the cells are dividing
HER2 status and other tumour features
Age, menopausal status, and overall health
How consistently hormone therapy is taken for the full prescribed duration

Your oncologist can share outcome information specific to your stage and tumour features, which is far more meaningful than general statistics.

Can Hormone Receptor Positive Breast Cancer Come Back?

Yes, it can, including many years after treatment.

Hormone receptor positive cancers have a recognised pattern of occasionally returning late, which is one reason hormone therapy is given for several years and follow-up continues long term. Regular check-ups, awareness of new symptoms, and completing the planned hormone therapy all help.

Living Well During and After Treatment

Stay physically active as advised by your care team
Maintain a healthy weight and balanced diet
Limit alcohol and avoid tobacco
Attend all follow-up visits and scans as scheduled
Seek support for emotional wellbeing, which is an important part of recovery

Medical Review

Hormone receptor positive breast cancer is the most common type of breast cancer and one of the most treatable, because its reliance on hormones gives doctors effective ways to control it. Treatment typically combines surgery with hormone therapy, with radiation, chemotherapy, and targeted therapy added according to the individual's stage and tumour features.

The outlook is often favourable, particularly with early detection and consistent hormone therapy, though long-term follow-up remains important because late recurrence can occur.

Consult the Breast Cancer Team at Renova Hospitals

If you or a family member has been diagnosed with breast cancer, or you want a second opinion on a hormone receptor positive result, our oncology team can help you understand the options.

At Renova Hospitals, our Breast Oncology, Medical Oncology, and Radiation Oncology teams plan treatment together, with receptor testing and multidisciplinary review. Dr. Jyosthna Elagandula, a Medical and Hemato-Oncologist at Renova Century Hospital with over 15 years of experience in solid tumours including breast cancer and in hormonal and targeted therapy, and the wider team can help you understand the plan for your case.

Request a consultation or call 040 2333 3333.

Questions to Ask Your Oncology Team

What are my ER, PR, and HER2 results, and what do they mean for my plan?
Which hormone therapy is recommended for me, and for how long?
Do I need chemotherapy, radiation, or targeted therapy as well?
How will side effects be managed, and how often will I be followed up?

Clear answers to these questions can help you take an active part in your treatment.

The Bottom Line

Hormone receptor positive breast cancer is the most common form of breast cancer, and its hormone dependence provides a powerful way to treat it. Most plans combine surgery with hormone therapy for several years, adding radiation, chemotherapy, or targeted therapy when the stage and tumour features call for it, and the outlook is often favourable when it is found early and treated consistently.

At Renova Hospitals, our oncology teams build an individual plan around each patient's receptor status, stage, and preferences, and stay with them through long-term follow-up.

Medical References

Medically Reviewed & Approved By

Dr. Jyosthna Elagandula

MBBS, MD, DM (Medical Oncology), DrNB (Medical Oncology), PDCR, ECMO

Senior Medical and Hemato-Oncologist, Renova Century Hospital, Banjara Hills, Hyderabad

This article has been reviewed and approved by a qualified medical professional to ensure medical accuracy and adherence to current clinical standards.

Want to connect with a specialist?

Book your appointment now

Book Consultation

Our Panel of Doctors

Our healthcare specialists are equipped with the knowledge and skills to provide you with the support you require. From consultation to diagnosis to treatments, our experts are dedicated to helping you.

Dr. Jyosthna Elagandula

Medical Oncology, Hemato-Oncology & BMT

15 years Experience

English, Hindi, Telugu

Renova Century Hospital - Banjara Hills

MBBS, MD, DM (Medical Oncology), DrNB (Medical Onc...

Doctor Profile Book Appointment

Recent Blogs

Comparing angioplasty and bypass surgery for blocked heart arteries

Cardiology

Coronary Angioplasty vs Bypass Surgery: How Doctors Decide

09 November 2026 | By Dr. Nirmal Kumar

Understand the differences between coronary angioplasty and bypass surgery, including how doctors assess blocked arterie...

Who is a candidate for spinal cord stimulation for chronic pain?

Neurosurgery

Spinal Cord Stimulation for Chronic Pain: Who Is a Candidate?

06 November 2026 | By Dr. Syed Ameer Basha Paspala

Learn how spinal cord stimulation helps manage certain types of chronic pain, who may be eligible for this treatment, an...

Brain tumour surgery recovery timeline and post-operative care

Neurosurgery

Brain Tumour Surgery Recovery: What to Expect Week by Week

04 November 2026 | By Dr. Vishnu Vardhan

Understand the week-by-week recovery process after brain tumour surgery, including healing milestones, common post-opera...

How TrueBeam radiotherapy differs from conventional radiation therapy

Radiation Oncology

TrueBeam Radiotherapy: How It Differs From Conventional Radiation

30 October 2026 | By Dr. Nethula Gauthami

Discover how TrueBeam radiotherapy differs from conventional radiation therapy, including its precision, treatment deliv...

Comparing blood cancer and solid tumour treatment approaches

Medical Oncology

Blood Cancer vs Solid Tumour: How Diagnosis and Treatment Differ

28 October 2026 | By Dr. Goli Vasu Babu

Understand how blood cancers and solid tumours differ in diagnosis, medical evaluation, and treatment approaches, includ...

Understanding HIPEC surgery for peritoneal cancer treatment

Surgical Oncology

HIPEC Surgery: What Patients With Peritoneal Cancer Need to Know

26 October 2026 | By Dr. Srinivas Juluri

Learn about HIPEC surgery for peritoneal cancer, including how the procedure works, its potential benefits, eligibility...

View All

Frequently Asked Questions

Find quick answers to common questions about our services, doctors, and care at Renova Hospitals. So you can feel informed and confident at every step.